Cargando…
Plasma and urine biomarkers in chronic kidney disease: closer to clinical application
Chronic kidney disease (CKD) is a silent disease, causing significant health and economic burden worldwide. It is of strong clinical value to identify novel prognostic, predictive, and pharmacodynamic biomarkers of kidney function, as current available measures have limitations. We reviewed the adva...
Autores principales: | Zabetian, Azadeh, Coca, Steven G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8490303/ https://www.ncbi.nlm.nih.gov/pubmed/34475336 http://dx.doi.org/10.1097/MNH.0000000000000735 |
Ejemplares similares
-
Mitochondrial DNA – novel mechanisms of kidney damage and potential biomarker
por: Malik, Afshan N.
Publicado: (2023) -
Safety of intravenous iron use in chronic kidney disease
por: Kalra, Philip A., et al.
Publicado: (2016) -
Dietary sodium restriction: a neglected therapeutic opportunity in chronic kidney disease
por: Humalda, Jelmer K., et al.
Publicado: (2014) -
Exercise as a therapeutic intervention in chronic kidney disease: are we nearly there yet?
por: Castle, Ellen M., et al.
Publicado: (2023) -
Which patients with CKD will benefit from genomic sequencing? Synthesizing progress to illuminate the future
por: Mallett, Andrew J.
Publicado: (2022)